Skip to content

Coronavirus (COVID-19) Local News

'Can't keep a waitlist': B.C. dog trainer busier than ever with pandemic puppies

'Can't keep a waitlist': B.C. dog trainer busier than ever with pandemic puppies

A Colwood business owner has never been so busy. She says she's currently working with 60 dogs.
B.C. goes three days without a COVID-19 death

B.C. goes three days without a COVID-19 death

B.C. officials detect 89 new COVID-19 cases – the most in a day since June 20.
Burnaby COVID-19 cases nearly double in a week - now more than Surrey

Burnaby COVID-19 cases nearly double in a week - now more than Surrey

Burnaby sees almost 30 new cases from July 11 to 17
Burnaby no longer holds 0% COVID-19 positivity rates as B.C. cases climb

Burnaby no longer holds 0% COVID-19 positivity rates as B.C. cases climb

B.C. cases continue to get closer to 100 a day
New B.C. COVID-19 cases rise again, hit four-week high

New B.C. COVID-19 cases rise again, hit four-week high

Number of those in B.C. hospitals with COVID-19 declines to 10-month low.
New B.C. COVID-19 cases spike to near-four-week high

New B.C. COVID-19 cases spike to near-four-week high

Active infections rise more than 8% in past week, to 692.
Burnaby COVID-19 vaccination rates inching closer to 85%

Burnaby COVID-19 vaccination rates inching closer to 85%

Burnaby Northwest has reached 85%
B.C. COVID-19 hospitalizations at 10-month low

B.C. COVID-19 hospitalizations at 10-month low

Number of those in hospital with the disease fell by 11 over the weekend, to 49.
Visitor restrictions at B.C.'s long-term care homes have lifted

Visitor restrictions at B.C.'s long-term care homes have lifted

Checking in with greeters during visiting hours, presenting proof of vaccination, and wearing a mask when travelling through common areas of the care home will still be required.
Burnaby company to get up to $4.5M from the feds to develop oral COVID-19 vaccine

Burnaby company to get up to $4.5M from the feds to develop oral COVID-19 vaccine

A Burnaby company is receiving advisory services and research and development funding of up to $4.57 million from a federal agency to help develop an orally administered COVID-19 vaccine.